Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia.

Manal Faleh AlMutairiAyla M TourkmaniAlian A AlrasheedyTurki J ALHarbiAbdulaziz M Bin RsheedMohammed ALjehaniYazed AlRuthia

Published in: Therapeutic advances in chronic disease (2021)

Telemedicine care is cost-effective in managing type 2 patients with poorly controlled diabetes. Consequently, we believe that telemedicine care can be further expanded and incorporated into routine diabetes care.

Keyphrases

healthcare
palliative care
quality improvement
type diabetes
cardiovascular disease
affordable care act
glycemic control
metabolic syndrome
adipose tissue
weight loss
chronic pain